NA
Nascent Pharma Holdings, Inc.
NASC · OTC
$0.01 +9.59% (+$0.00)
1M -16.16%
Market Cap $910.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 107.66%
ROA 3,406.45%
Debt
50 /100
Moderate Net debt/EBITDA -1.08x
Current ratio 0.02x
Int. coverage -4.50x
Stability
55 /100
Moderate EPS volatility 15.06%
Beta 0.60x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NASC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marco Alfonsi
Employees
12
Headquarters
Hicksville
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report